Roger F. Soll’s presentation is made possible by support from the Vermont Oxford Network for which he serves as Vice President and Director of Clinical Trials and Follow-up, Cochrane Neonatal Coordinating Editor. He did not receive fees, honoraria, or financial support from NEO: The Conference for Neonatology, Mednax, or any of its commercial sponsors for participation in this meeting.